TürkiyeOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Cardiovascular System & Hematology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 1,958 out of 210,400 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 53,446 | 46,484 |
| Total Cites | 5,062 | 6,265 |
| H-index | 36 | 41 |
| Hm-index | 21 | 24 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 199 | 246 |
| Number of Single+First Authored Papers | 68 | 68 |
| Total Cites to Single+First Authored Papers | 3,011 | 3,712 |
| Number of Single+First+Last Authored Papers | 119 | 119 |
| Total Cites to Single+First+Last Authored Papers | 4,694 | 5,732 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3,354 | 3,635 |
| Ratio of Total Citations to Distinct Citing Papers | 1.51 | 1.72 |
| Self-Citation Percentage |
19.20%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Cardiovascular System & Hematology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 1,959 out of 199,278 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 53,060 | 44,501 |
| Total Cites | 4,653 | 5,839 |
| H-index | 34 | 40 |
| Hm-index | 20 | 23 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 190 | 237 |
| Number of Single+First Authored Papers | 68 | 68 |
| Total Cites to Single+First Authored Papers | 2,753 | 3,443 |
| Number of Single+First+Last Authored Papers | 119 | 119 |
| Total Cites to Single+First+Last Authored Papers | 4,314 | 5,340 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3,093 | 3,368 |
| Ratio of Total Citations to Distinct Citing Papers | 1.50 | 1.73 |
| Self-Citation Percentage |
20.31%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Cardiovascular System & Hematology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 1,944 out of 192,021 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 52,498 | 44,409 |
| Total Cites | 4,437 | 5,589 |
| H-index | 34 | 39 |
| Hm-index | 20 | 22 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 188 | 235 |
| Number of Single+First Authored Papers | 68 | 68 |
| Total Cites to Single+First Authored Papers | 2,648 | 3,321 |
| Number of Single+First+Last Authored Papers | 118 | 118 |
| Total Cites to Single+First+Last Authored Papers | 4,112 | 5,108 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,965 | 3,234 |
| Ratio of Total Citations to Distinct Citing Papers | 1.50 | 1.73 |
| Self-Citation Percentage |
20.61%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Cardiovascular System & Hematology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 1,956 out of 152,312 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 50,958 | 42,880 |
| Total Cites | 4,051 | 5,169 |
| H-index | 32 | 37 |
| Hm-index | 19 | 22 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 183 | 230 |
| Number of Single+First Authored Papers | 68 | 68 |
| Total Cites to Single+First Authored Papers | 2,418 | 3,078 |
| Number of Single+First+Last Authored Papers | 118 | 118 |
| Total Cites to Single+First+Last Authored Papers | 3,755 | 4,725 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,679 | 2,939 |
| Ratio of Total Citations to Distinct Citing Papers | 1.51 | 1.76 |
| Self-Citation Percentage |
21.63%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.